Jubilant Life Sciences’ consolidated revenue for the quarter ended on September 2018 stood at Rs. 2,269 crore, up by 38 per cent YoY. This was led by stellar performance across all the segment, Pharmaceuticals division which account for 58 per cent of revenue recorded 55 per cent yoy growth.